Sangamo Therapeutics, Inc. (0R1D.L)
USD 2.62
(-3.68%)
USD 2.62
(-3.68%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 176.23 Million | 111.29 Million | 110.7 Million | 118.19 Million | 102.42 Million | 84.45 Million |
| Cost of Revenue | 221.55 Million | 12.1 Million | 9.43 Million | 180.64 Million | 145.92 Million | 114.86 Million |
| Gross Profit | -45.32 Million | 99.19 Million | 101.26 Million | -62.45 Million | -43.49 Million | -30.41 Million |
| Operating Expenses | 228.68 Million | 312.58 Million | 294.03 Million | 247.74 Million | 207.6 Million | 161.6 Million |
| Selling, General and Administrative Expenses | 61.16 Million | 62.68 Million | 63.21 Million | 67.09 Million | 61.68 Million | 46.73 Million |
| Research and Development Expenses | 234.05 Million | 249.89 Million | 230.81 Million | 180.64 Million | 145.92 Million | 114.86 Million |
| Other Expenses | -66.54 Million | - | - | - | - | - |
| Cost and Expenses | 450.23 Million | 312.58 Million | 294.03 Million | 247.74 Million | 207.6 Million | 161.6 Million |
| Operating Income | -274 Million | -201.28 Million | -183.33 Million | -129.55 Million | -105.18 Million | -77.15 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -5.07 Million | 429 Thousand | 306 Thousand | 345 Thousand | -19.6 Million | 8.26 Million |
| Earnings before Tax | -262.9 Million | -191.84 Million | -177.99 Million | -120.77 Million | -95.41 Million | -68.88 Million |
| Net Income | -257.83 Million | -192.27 Million | -178.29 Million | -121.12 Million | -75.81 Million | -68.33 Million |
| Earnings Per Share Basic | -1.48 | -1.25 | -1.23 | -0.90 | -0.68 | -0.70 |
| Earnings Per Share Diluted | -1.48 | -1.25 | -1.23 | -0.90 | -0.68 | -0.70 |
| Weighted Average Shares Outstanding | 174.44 Million | 154.34 Million | 144.56 Million | 134.44 Million | 112.11 Million | 96.94 Million |
| Weighted Average Shares Outstanding (Diluted) | 174.44 Million | 154.34 Million | 144.56 Million | 134.44 Million | 112.11 Million | 96.94 Million |
| Gross Margin | -0.26 | 0.89 | 0.91 | -0.53 | -0.42 | -0.36 |
| EBIT Margin | -0.50 | -1.81 | -1.66 | -1.10 | -1.03 | -0.91 |
| Profit Margin | -1.46 | -1.73 | -1.61 | -1.02 | -0.74 | -0.81 |
| EBITDA | -87.42 Million | -189.17 Million | -173.89 Million | -123.87 Million | -101.25 Million | -74.79 Million |
| Earnings Before Tax Margin | -1.55 | -1.81 | -1.66 | -1.10 | -1.03 | -0.91 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 356 Thousand | 481 Thousand | 2.04 Million | 176.23 Million | 9.39 Million | 6.83 Million |
| Cost of Revenue | 2.57 Million | 2.52 Million | 2.98 Million | 22.19 Million | 9.51 Million | 4.25 Million |
| Gross Profit | -2.21 Million | -2.04 Million | -940 Thousand | 154.04 Million | -113 Thousand | 2.57 Million |
| Operating Expenses | 31.82 Million | 43.33 Million | 61.42 Million | 268.33 Million | 71 Million | 79.06 Million |
| Selling, General and Administrative Expenses | 7.07 Million | 8.74 Million | 10.21 Million | - | 13.91 Million | 16.01 Million |
| Research and Development Expenses | 24.75 Million | 34.59 Million | 51.2 Million | - | 57.08 Million | 63.04 Million |
| Other Expenses | 1.17 Million | 4.34 Million | 296 Thousand | 155.01 Million | 44.79 Million | 51.34 Million |
| Cost and Expenses | 34.39 Million | 45.85 Million | 64.4 Million | 290.52 Million | 71 Million | 79.06 Million |
| Operating Income | -34.03 Million | -45.37 Million | -62.36 Million | -114.29 Million | -106.4 Million | -123.57 Million |
| Interest Expense | - | - | -113.84 Million | - | - | - |
| Income Tax Expense | 74 Thousand | 98 Thousand | -272 Thousand | -5.07 Million | 1.27 Million | -6.26 Million |
| Earnings before Tax | -36.05 Million | -48.99 Million | -60.56 Million | -262.9 Million | -102.89 Million | -120.77 Million |
| Net Income | -36.12 Million | -49.08 Million | -60.29 Million | -257.83 Million | -104.16 Million | -114.5 Million |
| Earnings Per Share Basic | -0.18 | -0.27 | -0.34 | - | -0.59 | -0.66 |
| Earnings Per Share Diluted | -0.18 | -0.27 | -0.34 | - | -0.59 | -0.66 |
| Weighted Average Shares Outstanding | 203.94 Million | 180.34 Million | 177.61 Million | 174.44 Million | 176.54 Million | 174.32 Million |
| Weighted Average Shares Outstanding (Diluted) | 203.94 Million | 180.34 Million | 177.61 Million | 174.44 Million | 177.17 Million | 174.32 Million |
| Gross Margin | -6.23 | -4.25 | -0.46 | 0.87 | -0.01 | 0.38 |
| EBIT Margin | -88.39 | -89.09 | -29.08 | - | -1.79 | -2.15 |
| Profit Margin | -101.48 | -102.06 | -29.53 | -1.46 | -11.08 | -16.75 |
| EBITDA | -31.46 Million | -42.85 Million | -59.38 Million | - | -16.81 Million | -14.69 Million |
| Earnings Before Tax Margin | -95.62 | -94.34 | -30.54 | -0.65 | -11.32 | -18.08 |
ZLAB
SFR
NVS
HSTO
7282
VIBE